Vienna - Delayed Quote EUR
DexCom, Inc. (DXCM.VI)
72.26
-0.12
(-0.17%)
As of 1:00:28 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 25 | 25 |
| Avg. Estimate | 1.12B | 1.17B | 4.61B | 5.31B |
| Low Estimate | 1.12B | 1.14B | 4.57B | 5.07B |
| High Estimate | 1.15B | 1.2B | 4.68B | 5.59B |
| Year Ago Sales | 1B | 994.2M | 4.03B | 4.61B |
| Sales Growth (year/est) | 11.86% | 17.66% | 14.26% | 15.32% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DXCM.VI | -- | -- | -- | -- |
| S&P 500 | 12.38% | 3.18% | 8.00% | 13.86% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 5/5/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/2/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/2/2025 |
| Maintains | Baird: Outperform to Outperform | 5/2/2025 |
| Initiated | Mizuho: Outperform | 4/10/2025 |
| Maintains | Citigroup: Buy to Buy | 3/4/2025 |